BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension
about
BMPR2 spruces up the endothelium in pulmonary hypertensionThe Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary FibrosisDNA Damage and Pulmonary HypertensionMitochondrial Haplogroups and Risk of Pulmonary Arterial HypertensionEmerging Metabolic Therapies in Pulmonary Arterial Hypertension.Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionThe cancer theory of pulmonary arterial hypertension.Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target SlugVascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertensionAmphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertensionDiscerning functional hierarchies of microRNAs in pulmonary hypertension.Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Critical effects of epigenetic regulation in pulmonary arterial hypertension.Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension.Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunctionUpdate on novel targets and potential treatment avenues in pulmonary hypertension.Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.Suppression of endothelial PGC-1α is associated with hypoxia-induced endothelial dysfunction and provides a new therapeutic target in pulmonary arterial hypertension.Mitochondrial and Metabolic Drivers of Pulmonary Vascular Endothelial Dysfunction in Pulmonary Hypertension.PPARγ Regulates Mitochondrial Structure and Function and HPASMC Proliferation.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.Oxidative stress increases M1dG, a major peroxidation-derived DNA adduct, in mitochondrial DNA.DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS.Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung.YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series).Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cellsMitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountainsConsequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
P2860
Q26786834-1D105078-8573-47B4-89E6-614B0AB1E4D9Q26786969-5C9F51DC-D0B0-42B9-9EA7-B3B703A0A6E8Q27005594-FA35C667-88BA-43C5-BB4D-DEE70CDBA153Q28602210-01774518-2582-471E-BE63-9915628E1AACQ33608219-3C307720-51DC-4A59-ADD8-956EF133DBBAQ33738642-8C07DC1F-6807-43B9-8068-151C7938058DQ33788493-F960649E-00F2-4E7E-87AC-B933D56A5AFBQ36480359-410E54B2-DBD0-40B2-9CEB-74234315B6A6Q36869381-0CAEE03F-F927-410B-A9C4-90C3313C5096Q37217460-F195F8F6-FDF9-4C3F-8896-919B8484DFCEQ37599544-A383AF8C-B422-4BAA-8A54-C3439CB0AF17Q37677437-764C09BB-37AD-4DBF-B507-04F2A2BC33E8Q38778206-287039D0-D962-4916-9C52-39824B592BDBQ38779774-727B9689-1A24-46D3-B042-3BC3F410819FQ39345470-5A09322A-82C6-44A9-ACD2-0A6BCAC05231Q41022731-A96B8251-FFDB-4B24-B97C-7509647BFC8EQ41763904-D0E3F42E-8C56-4C23-9541-78D48AD9E95CQ42784219-860F27F7-73D4-4571-9FCA-59C83BF2C9E8Q46516719-92D25AFD-FEC6-4418-B2F9-44E843C1621FQ46562780-15FC0453-84AA-4978-B731-A1830F45E87EQ47187664-87B9928D-4445-423C-A88B-46A6BC0A673BQ47356839-B41A36FA-0988-406A-9B31-38A285FCA50AQ47726007-8D0F00BB-4259-416A-B46B-8A86AA75EB11Q50041340-E8C1A869-7B25-4FEF-8200-7717F8E7142BQ50124360-B82C4A9F-F0FE-4D94-85B6-8FC4A6DDF6CEQ50942066-C4C5A2CC-F19E-4778-9EA4-EFEA7AACE1F0Q52312349-DA557397-AB7A-4A36-BE38-9332F6DF2D98Q52572356-BFF0DD89-691A-4DCC-81AA-DF75204A0607Q52889395-35EB696F-BA9D-4AF3-9B8F-8F222C251CDDQ55008475-F496DD9D-9350-4084-B717-33BA4C5D35BBQ55112828-0B688D97-21AB-4420-BE17-9BEB39EEB85BQ57070238-4632BC00-E0A4-43E2-8C8F-2744C0EA2FC1Q57091761-C8731687-D5FA-4FBA-A2E2-39891FA689D9Q58703705-CF61C476-4B7B-4A0A-AD93-17765C6DF0EE
P2860
BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
BMPR2 preserves mitochondrial ...... reverse pulmonary hypertension
@ast
BMPR2 preserves mitochondrial ...... reverse pulmonary hypertension
@en
type
label
BMPR2 preserves mitochondrial ...... reverse pulmonary hypertension
@ast
BMPR2 preserves mitochondrial ...... reverse pulmonary hypertension
@en
prefLabel
BMPR2 preserves mitochondrial ...... reverse pulmonary hypertension
@ast
BMPR2 preserves mitochondrial ...... reverse pulmonary hypertension
@en
P2093
P2860
P1433
P1476
BMPR2 preserves mitochondrial ...... reverse pulmonary hypertension
@en
P2093
Caiyun G Li
Isabel Diebold
Kazuya Miyagawa
Kiichi Nakahira
Lingli Wang
Mark Kaschwich
Marlene Rabinovitch
Miguel A Alejandre Alcazar
P2860
P304
P356
10.1016/J.CMET.2015.03.010
P577
2015-04-01T00:00:00Z